Early research (Phase 1)Study completedNCT05739292
What this trial is testing
Safety and Immunogenicity of Pentavalent Meningococcal Conjugate Vaccine (EuNmCV-5) in Healthy Adults Aged 19 to 55 Years Old
Who this might be right for
Infection, Meningococcal
EuBiologics Co.,Ltd 60